Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 12:27 PM ET | Feedback | Site Changes | Help
A mid-cap biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies.
View All Commentary (OSIP)
Recs
ellinajohn (56.00) Submitted: 7/18/08 2:51 AM : Start Price: $48.80 OSIP Score: 0.96
target price $50-58
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK